博济医药：子公司取得1项专利证书

Core Viewpoint - Boji Pharmaceutical announced that its wholly-owned subsidiary, Xinglin Traditional Chinese Medicine Technology (Guangzhou) Co., Ltd., has received a patent certificate from the National Intellectual Property Administration for an invention titled "A Liver-targeted Alkylating Agent and Its Application" [1] Group 1 - The patent awarded is significant for the company's research and development efforts in targeted therapies [1] - The invention focuses on a specific application in liver treatment, indicating potential advancements in medical technology [1]